GlassScriptPhysician profile
John J Braswell
NPI 1164493458
$7,985.53
in general payments reported to CMS, 2019-2025
30 companies · $1,309 in 2025
The $1,309 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,851 · 2020: $1,213 · 2021: $965 · 2022: $454 · 2023: $332 · 2024: $862 · 2025: $1,309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,679 · Travel and Lodging: $824.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,678.94 |
| Travel and Lodging | $823.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,297.67 | 2019-2025 | Proclaim, Eterna, Octrode |
| Vertiflex, INC. | $2,212.83 | 2019 | |
| Stryker Corporation | $914.90 | 2025 | Mild Device Kit |
| Boston Scientific Corporation | $438.03 | 2020-2025 | General - Pain Management |
| Si-Bone, INC. | $312.82 | 2020-2024 | |
| Collegium Pharmaceutical, INC. | $248.63 | 2019-2025 | Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $214.14 | 2019-2024 | Relistor |
| Amgen INC. | $183.23 | 2019-2022 | |
| Saluda Medical Americas, INC. | $158.44 | 2025 | Evoke |
| Medtronic, INC. | $141.83 | 2021-2025 | Kyphon Express II Kyphopak Tray, Inceptiv |
| Medtronic USA, INC. | $130.20 | 2019-2020 | |
| Abbvie INC. | $102.83 | 2021-2023 | Ubrelvy |
| Novartis Pharmaceuticals Corporation | $99.28 | 2019-2021 | |
| Nevro Corp. | $73.66 | 2020-2021 | |
| Valinor Pharma, LLC | $52.82 | 2024-2025 | Movantik |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $48.59 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $48.55 | 2020-2021 | |
| Mdd US Operations, LLC | $47.58 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $43.82 | 2020 | |
| Globus Medical, INC. | $33.24 | 2025 | Senza |
| Allergan, INC. | $30.21 | 2020 | |
| Averitas Pharma INC. | $21.42 | 2023 | Qutenza |
| Nalu Medical, INC. | $19.15 | 2021 | |
| Arbor Pharmaceuticals, INC. | $18.46 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $17.34 | 2023 | Exparel, Iovera, Zilretta |
| Tersera Therapeutics LLC | $16.91 | 2019 | |
| Ibsa Pharma INC. | $16.91 | 2023 | Tirosint, Licart |
| Biodelivery Sciences International, INC. | $15.92 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $14.74 | 2025 | |
| Sentynl Therapeutics, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Braswell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.